Matthias Huber

2.2k total citations
40 papers, 751 citations indexed

About

Matthias Huber is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Ophthalmology. According to data from OpenAlex, Matthias Huber has authored 40 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Ophthalmology. Recurrent topics in Matthias Huber's work include Hormonal Regulation and Hypertension (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Retinal Diseases and Treatments (4 papers). Matthias Huber is often cited by papers focused on Hormonal Regulation and Hypertension (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Retinal Diseases and Treatments (4 papers). Matthias Huber collaborates with scholars based in Germany, France and Denmark. Matthias Huber's co-authors include Reinhold Kreutz, Juliane Bolbrinker, Gary D. Monheit, Rhoda S. Narins, Fredric S Brandt, Rod J. Rohrich, Michael A. C. Kane, Kirsten Siepmann, Nicole Stübiger and Christoph Deuter and has published in prestigious journals such as PLoS ONE, Diabetes and International Journal of Molecular Sciences.

In The Last Decade

Matthias Huber

38 papers receiving 709 citations

Peers

Countries citing papers authored by Matthias Huber

Since Specialization

Citations

This map shows the geographic impact of Matthias Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Huber more than expected).

Fields of papers citing papers by Matthias Huber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Huber. The network helps show where Matthias Huber may publish in the future.

Co-authorship network of co-authors of Matthias Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Huber. A scholar is included among the top collaborators of Matthias Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Huber. Matthias Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reproductive aging weakens offspring survival and constrains the telomerase response to herpesvirus in Pacific oysters 2024 ·Science Advances ·Andréaz Dupoué, (unknown), Matthias Huber, (unknown), Jacqueline Le Grand, Charlotte Corporeau, Elodie Fleury, Benoı̂t Bernay, Pierre de Villemereuil, Benjamín Morga, Jérémy Le Luyer	0
2	pH controls spermatozoa motility in the Pacific oyster (Crassostrea gigas) 2018 ·Biology Open ·Myrina Boulais, Marc Suquet, Eve-Julie Arsenault-Pernet, (unknown), Isabelle Quéau, Patricia Pignet, (unknown), Jacqueline Le Grand, Matthias Huber, Jacky Cosson	22
3	Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study 2018 ·Journal of Molecular Medicine ·Anika Witten, Juliane Bolbrinker, Andrei Barysenka, Matthias Huber, Frank Rühle, Ulrike Nowak‐Göttl, Edeltraut Garbe, Reinhold Kreutz, Monika Stoll	12
4	Target organ damage and control of cardiovascular risk factors in hypertensive patients 2015 ·Herz ·Rona Reibis, Matthias Huber, Marthin Karoff, W. Kamke, Reinhold Kreutz, Karl Wegscheider, Heinz Völler	7
5	Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance Study 2014 ·European Journal of Clinical Pharmacology ·Matthias Huber, Frank Andersohn, Giselle Sarganas, Elisabeth Bronder, Andreas Klimpel, Michael Thomae, (unknown), Reinhold Kreutz, Edeltraut Garbe	70
6	Arzneimittelsicherheit 2014 ·Der Nervenarzt ·Matthias Huber, (unknown), Shyama Chatterjee, Britta Haenisch, (unknown), Karl Broich	1
7	Dialysis-Associated Hypertension Treated with Telmisartan – DiaTel: A Pilot, Placebo-Controlled, Cross-Over, Randomized Trial 2013 ·PLoS ONE ·Matthias Huber, (unknown), Peter Martus, (unknown), Reinhold Kreutz, Joachim Beige	3
8	Vitreous Levels of Proteins Implicated in Angiogenesis Are Modulated in Patients with Retinal or Choroidal Neovascularization 2012 ·Ophthalmologica ·Matthias Huber, J Wachtlin	22
9	Ophthalmic Drugs as Part of Polypharmacy in Nursing Home Residents with Glaucoma 2012 ·Drugs & Aging ·Matthias Huber, (unknown), Ralf Stahlmann, Werner Hofmann, Juliane Bolbrinker, Dagmar Dräger, Reinhold Kreutz	14
10	Genetic variants implicated in telomere length associated with left ventricular function in patients with hypertension and cardiac organ damage 2012 ·Journal of Molecular Medicine ·Matthias Huber, András Treszl, Markus Wehland, (unknown), (unknown), Rona Reibis, Juliane Bolbrinker, Monika Stoll, Gilbert Schönfelder, Karl Wegscheider, Heinz Völler, Reinhold Kreutz	12
11	Role of CYP2C9 genetic variants for salt sensitivity and the regulation of the renin–angiotensin–aldosterone system in normotensive men 2010 ·Journal of Hypertension ·Juliane Bolbrinker, Joachim Beige, Matthias Huber, Arya M. Sharma, Alexander Thomas, Hans‐Christian Deter, Reinhold Kreutz	4
12	Microangiopathy and visual deficits characterize the retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome 2010 ·Hypertension Research ·Matthias Huber, Peter Heiduschka, Focke Ziemssen, Juliane Bolbrinker, Reinhold Kreutz	8
13	Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects 2009 ·Fundamental and Clinical Pharmacology ·Juliane Bolbrinker, Matthias Huber, Jürgen Scholze, Reinhold Kreutz	12
14	A Twofold Genetic Increase of ACE Expression Has No Effect on the Development of Spontaneous Hypertension 2008 ·American Journal of Hypertension ·Ibrahim Nassar, Angela Schulz, (unknown), Ingrid M. Garrelds, Ralph Plehm, Matthias Huber, A.H. Jan Danser, Reinhold Kreutz	4
15	La pneumopathie associée à l’acitrétine : une complication du traitement du psoriasis à ne pas méconnaître 2007 ·La Revue de Médecine Interne ·(unknown), Matthias Huber, (unknown), (unknown), (unknown), P. Kieffer	4
16	Pharmacokinetics of Olmesartan Medoxomil plus Hydrochlorothiazide Combination in Healthy Subjects 2006 ·Clinical Drug Investigation ·Reinhold Kreutz, Juliane Bolbrinker, Matthias Huber	19
17	Approaching an individual methotrexate regimen in leptomeningeal carcinomatosis 2005 ·Journal of the Neurological Sciences ·Matthias Huber, (unknown), Steffen Bauer, Stefanie Leistner, Ulrike Schmitz, S. Seyfert	0
18	Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis 2005 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·Kirsten Siepmann, Matthias Huber, Nicole Stübiger, Christoph Deuter, Manfred Zierhut	65
19	Mycophenolate mofetil (MMF) is a highly effective and safe immunosuppressive agent for the treatment of uveitis 2004 ·Investigative Ophthalmology & Visual Science ·Manfred Zierhut, Matthias Huber, Nicole Stuebiger, Christoph Deuter, Kirsten Siepmann	1
20	Retinal function and morphology in two zebrafish models of oculo‐renal syndromes 2003 ·European Journal of Neuroscience ·(unknown), Matthias Huber, Oliver Rinner, Mathias W. Seeliger, Silke Geiger‐Rudolph, Robert Geisler, Stephan C. F. Neuhauss	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact